A protein-based drug injected into people who are just starting to show signs of diabetes can stop the disease in its tracks, two studies show. The research trials offer hope that early intervention can prevent or curtail type I, or juvenile-onset, diabetes.
In type I diabetes, the immune system destroys insulin-producing beta cells housed in the pancreas.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.